Market revenue in 2023 | USD 4,836.6 million |
Market revenue in 2030 | USD 8,973.7 million |
Growth rate | 9.2% (CAGR from 2023 to 2030) |
Largest segment | Tissue products |
Fastest growing segment | Immunosuppressive Drugs |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunosuppressive Drugs, Tissue Products, Preservation Solutions |
Key market players worldwide | AbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.
Tissue products was the largest segment with a revenue share of 57.38% in 2023. Horizon Databook has segmented the Europe transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.
According to the report published by NHS Blood and Transplant, during 2018-2019, around 3,951 transplant procedures were performed in the UK. The presence of a large number of organ donors in Europe is the prime reason for its dominance in the global transplantation market. The advances in transplantation technology and highly developed healthcare infrastructure in Europe have driven the number of transplantation procedures.
Growing demand for organ transplantation can be attributed to increase in the number of chronic diseases like cancers, renal diseases, and COPDs, which may lead to organ failures. FOEDUS joint action is an organization that facilitates exchange or donation of organs between European member states and raises awareness about organ donation in the region.
The program is funded by the Health Program of the EU. According to the International Registry in Organ Donation and Transplantation, the UK ranked second in terms of receiving organ donations from patients who succumbed to circulatory death. The rise in number of organ donors in the region has increased to a large extent, thereby driving the market.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe transplantation market , including forecasts for subscribers. This continent databook contains high-level insights into Europe transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account